Clinical trial
Regional Anesthesia and Breast Cancer Recurrence
NCT00418457 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00418457 |
|---|---|
| Title | Regional Anesthesia and Breast Cancer Recurrence |
| Official title | Regional Anesthesia and Breast Cancer Recurrence |
| Lead sponsor | The Cleveland Clinic, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | General anesthesia and opioids, Regional analgesia and propofol |
| Enrollment | 2,108 |
| Start date | Jan 1, 2007 |
| Primary completion | Feb 1, 2018 |
| Completion | Dec 1, 2019 |
| First posted | Jan 4, 2007 |
| Last update posted | Jun 16, 2020 |
| Countries | Austria, China, Germany, Ireland, Singapore, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: